Catalyst Wire Dossier Catalyst Wire Dossier

HU6

· Rivus Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for HU6, covering 2024-03-01 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH) [Phase 2]

See pricing